Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.
Study Type
OBSERVATIONAL
Enrollment
140
The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.
CHU de Liège
Liège, Belgium
Cell savage use
The primary outcome was the proportion of patients in whom the cell saver was effectively used (%)
Time frame: during the surgical procedure
Re-infused
Total volume of re-suspended blood re-infused (mL)
Time frame: during the surgical procedure
Hemoglobin
Post-operative hemoglobin level (g/dL)
Time frame: during the surgical procedure
Allogenic Transfusion
The need for allogenic blood transfusion (unit)
Time frame: 7 days
Aspirated blood
The total volume of blood aspirated into the reservoir (mL)
Time frame: during the surgical procedure
Fluid
The total amount of fluid infused (mL)
Time frame: during the surgical procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.